<p><strong>纽约，NY / ACCESS Newswire /2025 年 8 月 10 日/</strong> 如果您在 <strong>RxSight, Inc.</strong> 的投资中遭受了损失，并希望了解根据联邦证券法的潜在赔偿，请点击以下链接获取更多信息：</p>
<p>https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=160630&amp;wire=1&amp;utm_campaign=22</p>
<p>或通过电子邮件联系 Joseph E. Levi 律师，邮箱地址为 jlevi@levikorsinsky.com，或拨打 (212) 363-7500 与我们经验丰富的股东倡导团队联系。</p>
<p><strong>诉讼：</strong> 针对 RxSight, Inc.提起了一项集体诉讼，旨在为在 2024 年 11 月 7 日至 2025 年 7 月 8 日期间受到证券欺诈影响的股东追回损失。</p>
<p><strong>案件详情：</strong> 提起的投诉指控被告发表了虚假陈述和/或隐瞒了以下事实：(1) 公司面临 “采用挑战” 和/或结构性问题，导致销售和使用率下降；(2) 被告夸大了对 RxSight 产品的需求；(3) 因此，RxSight 不太可能达到其之前发布的 2025 财年的财务指导；(4) 因此，被告对公司业务、运营和前景的积极陈述在实质上具有误导性和/或缺乏合理依据。</p>
<p><strong>接下来怎么办？</strong> 如果您在相关时间段内在 RxSight, Inc.的股票中遭受了损失——即使您仍持有股份——请访问 https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=160630&amp;wire=1&amp;utm_campaign=22 了解您寻求赔偿的权利。<strong>参与没有费用或义务。</strong></p>
<p><strong>为什么选择 Levi &amp; Korsinsky：</strong> 在过去 20 年中，Levi &amp; Korsinsky LLP 已建立为全国知名的证券诉讼公司，为受害股东争取了数亿美元，并在高风险案件中赢得了良好的记录。该公司在复杂证券诉讼方面拥有丰富的经验，并拥有超过 70 名员工为客户服务。连续七年，Levi &amp; Korsinsky 在 ISS 证券集体诉讼服务的前 50 名报告中被评为美国顶级证券诉讼公司之一。律师广告。以往结果不保证类似结果。</p>
<p><strong>联系方式：</strong></p>
<p>Levi &amp; Korsinsky, LLP</p>
<p>Joseph E. Levi, Esq.</p>
<p>Ed Korsinsky, Esq.</p>
<p>33 Whitehall Street, 17th Floor</p>
<p>纽约，NY 10004</p>
<p>jlevi@levikorsinsky.com</p>
<p>电话：(212) 363-7500</p>
<p>传真：(212) 363-7171</p>
<p>https://zlk.com/</p>
<p><strong>来源：</strong> Levi &amp; Korsinsky, LLP</p>
<p>查看 ACCESS Newswire 上的原始新闻稿</p>

RXST

<p>针对 RxSight, Inc. (RXST) 提起了一项集体诉讼，指控其在 2024 年 11 月 7 日至 2025 年 7 月 8 日期间对股东进行证券欺诈。投诉称，该公司虚假陈述了其销售业绩，并夸大了产品需求，导致了重大财务损失。遭受损失的股东被鼓励在 2025 年 9 月 22 日之前联系 Levi & Korsinsky LLP 寻求潜在的赔偿选项。该律所在证券诉讼方面有着良好的业绩记录，并为受影响的投资者提供无成本参与的机会</p>

<p><strong>NEW YORK, NY / ACCESS Newswire / August 10, 2025 /</strong> If you suffered a loss on your <strong>RxSight, Inc.</strong> investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:</p>
<div class="lb-trans"><p><strong>纽约，NY / ACCESS Newswire /2025 年 8 月 10 日/</strong> 如果您在 <strong>RxSight, Inc.</strong> 的投资中遭受了损失，并希望了解根据联邦证券法的潜在赔偿，请点击以下链接获取更多信息：</p>
</div><p>https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=160630&amp;wire=1&amp;utm_campaign=22</p>
<div class="lb-trans"><p>https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=160630&amp;wire=1&amp;utm_campaign=22</p>
</div><p>or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.</p>
<div class="lb-trans"><p>或通过电子邮件联系 Joseph E. Levi 律师，邮箱地址为 jlevi@levikorsinsky.com，或拨打 (212) 363-7500 与我们经验丰富的股东倡导团队联系。</p>
</div><p><strong>THE LAWSUIT:</strong> A class action securities lawsuit was filed against RxSight, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between November 7, 2024 and July 8, 2025.</p>
<div class="lb-trans"><p><strong>诉讼：</strong> 针对 RxSight, Inc.提起了一项集体诉讼，旨在为在 2024 年 11 月 7 日至 2025 年 7 月 8 日期间受到证券欺诈影响的股东追回损失。</p>
</div><p><strong>CASE DETAILS:</strong> The filed complaint alleges that defendants made false statements and/or concealed that: (1) the Company was experiencing &#34;adoption challenges&#34; and/or structural issues resulting in declines in sales and utilization; (2) defendants had overstated the demand for RxSight's products; (3) as a result, RxSight was unlikely to meet its own previously issued financial guidance for fiscal year 2025; and (4) that, as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.</p>
<div class="lb-trans"><p><strong>案件详情：</strong> 提起的投诉指控被告发表了虚假陈述和/或隐瞒了以下事实：(1) 公司面临 “采用挑战” 和/或结构性问题，导致销售和使用率下降；(2) 被告夸大了对 RxSight 产品的需求；(3) 因此，RxSight 不太可能达到其之前发布的 2025 财年的财务指导；(4) 因此，被告对公司业务、运营和前景的积极陈述在实质上具有误导性和/或缺乏合理依据。</p>
</div><p><strong>WHAT'S NEXT?</strong> If you suffered a loss in RxSight, Inc. stock during the relevant time frame - even if you still hold your shares - go to https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=160630&amp;wire=1&amp;utm_campaign=22 to learn about your rights to seek a recovery. <strong>There is no cost or obligation to participate.</strong></p>
<div class="lb-trans"><p><strong>接下来怎么办？</strong> 如果您在相关时间段内在 RxSight, Inc.的股票中遭受了损失——即使您仍持有股份——请访问 https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=160630&amp;wire=1&amp;utm_campaign=22 了解您寻求赔偿的权利。<strong>参与没有费用或义务。</strong></p>
</div><p><strong>WHY LEVI &amp; KORSINSKY:</strong> Over the past 20 years, Levi &amp; Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p><strong>为什么选择 Levi &amp; Korsinsky：</strong> 在过去 20 年中，Levi &amp; Korsinsky LLP 已建立为全国知名的证券诉讼公司，为受害股东争取了数亿美元，并在高风险案件中赢得了良好的记录。该公司在复杂证券诉讼方面拥有丰富的经验，并拥有超过 70 名员工为客户服务。连续七年，Levi &amp; Korsinsky 在 ISS 证券集体诉讼服务的前 50 名报告中被评为美国顶级证券诉讼公司之一。律师广告。以往结果不保证类似结果。</p>
</div><p><strong>CONTACT:</strong></p>
<div class="lb-trans"><p><strong>联系方式：</strong></p>
</div><p>Levi &amp; Korsinsky, LLP</p>
<div class="lb-trans"><p>Levi &amp; Korsinsky, LLP</p>
</div><p>Joseph E. Levi, Esq.</p>
<div class="lb-trans"><p>Joseph E. Levi, Esq.</p>
</div><p>Ed Korsinsky, Esq.</p>
<div class="lb-trans"><p>Ed Korsinsky, Esq.</p>
</div><p>33 Whitehall Street, 17th Floor</p>
<div class="lb-trans"><p>33 Whitehall Street, 17th Floor</p>
</div><p>New York, NY 10004</p>
<div class="lb-trans"><p>纽约，NY 10004</p>
</div><p>jlevi@levikorsinsky.com</p>
<div class="lb-trans"><p>jlevi@levikorsinsky.com</p>
</div><p>Tel: (212) 363-7500</p>
<div class="lb-trans"><p>电话：(212) 363-7500</p>
</div><p>Fax: (212) 363-7171</p>
<div class="lb-trans"><p>传真：(212) 363-7171</p>
</div><p>https://zlk.com/</p>
<div class="lb-trans"><p>https://zlk.com/</p>
</div><p><strong>SOURCE:</strong> Levi &amp; Korsinsky, LLP</p>
<div class="lb-trans"><p><strong>来源：</strong> Levi &amp; Korsinsky, LLP</p>
</div><p>View the original press release on ACCESS Newswire</p>
<div class="lb-trans"><p>查看 ACCESS Newswire 上的原始新闻稿</p>
</div>

在 RxSight, Inc. (RXST) 上亏损？被敦促在2025年9月22日前加入集体诉讼 - 请联系 Levi & Korsinsky